1. Home
  2. CREG vs CVKD Comparison

CREG vs CVKD Comparison

Compare CREG & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CREG
  • CVKD
  • Stock Information
  • Founded
  • CREG N/A
  • CVKD 2022
  • Country
  • CREG China
  • CVKD United States
  • Employees
  • CREG N/A
  • CVKD N/A
  • Industry
  • CREG Power Generation
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • CREG Utilities
  • CVKD Health Care
  • Exchange
  • CREG Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • CREG 16.6M
  • CVKD 29.5M
  • IPO Year
  • CREG N/A
  • CVKD 2023
  • Fundamental
  • Price
  • CREG $0.24
  • CVKD $12.98
  • Analyst Decision
  • CREG
  • CVKD Strong Buy
  • Analyst Count
  • CREG 0
  • CVKD 1
  • Target Price
  • CREG N/A
  • CVKD $32.00
  • AVG Volume (30 Days)
  • CREG 4.7M
  • CVKD 32.3K
  • Earning Date
  • CREG 08-13-2025
  • CVKD 08-06-2025
  • Dividend Yield
  • CREG N/A
  • CVKD N/A
  • EPS Growth
  • CREG N/A
  • CVKD N/A
  • EPS
  • CREG N/A
  • CVKD N/A
  • Revenue
  • CREG $20,625.00
  • CVKD N/A
  • Revenue This Year
  • CREG N/A
  • CVKD N/A
  • Revenue Next Year
  • CREG N/A
  • CVKD N/A
  • P/E Ratio
  • CREG N/A
  • CVKD N/A
  • Revenue Growth
  • CREG N/A
  • CVKD N/A
  • 52 Week Low
  • CREG $0.20
  • CVKD $5.70
  • 52 Week High
  • CREG $1.47
  • CVKD $22.90
  • Technical
  • Relative Strength Index (RSI)
  • CREG 25.00
  • CVKD 49.60
  • Support Level
  • CREG $0.20
  • CVKD $11.00
  • Resistance Level
  • CREG $0.24
  • CVKD $13.71
  • Average True Range (ATR)
  • CREG 0.11
  • CVKD 1.12
  • MACD
  • CREG -0.00
  • CVKD 0.10
  • Stochastic Oscillator
  • CREG 2.16
  • CVKD 63.54

About CREG Smart Powerr Corp.

Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company offers waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: